Kisqali (600 MG Dose) and Lansoprazole Delayed-Release Capsules
Determining the interaction of Kisqali (600 MG Dose) and Lansoprazole Delayed-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
Generic Name: lansoprazole
Brand name: FIRST Lansoprazole, Prevacid, Prevacid OTC, Prevacid SoluTab
Synonyms: Lansoprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali (600 MG Dose)-Lansoprazole Orally Disintegrating Tablets
- Kisqali (600 MG Dose)-Lansoprazole, Amoxicillin, and Clarithromycin
- Kisqali (600 MG Dose)-Lanthanum
- Kisqali (600 MG Dose)-Lanthanum carbonate
- Kisqali (600 MG Dose)-Lanthanum Carbonate Tablets
- Kisqali (600 MG Dose)-Lanthanum Chewable Tablets
- Lansoprazole Delayed-Release Capsules-Kisqali Femara Co-Pack
- Lansoprazole Delayed-Release Capsules-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Lansoprazole Delayed-Release Capsules-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Lansoprazole Delayed-Release Capsules-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Lansoprazole Delayed-Release Capsules-Kitabis Pak
- Lansoprazole Delayed-Release Capsules-Kitabis Pak inhalation